Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio ...

Based on internal projections for demand, the two companies have approved about $150 million in additional investments to ...

Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.

The former SVP of global sales and the leader in sales engineering from Klaviyo have emerged from stealth with a new startup backed by Klaviyo founders, Asymmetric Capital Partners and Underscore VC.

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

Goods “put up another strong quarter” that “checked just about all of the boxes,” with comparable store sales growth of 6.4% ...

CL King analyst Andrew Wolf upgraded United Natural Foods (UNFI) to Buy from Neutral with a $33 price target Q2 results “beat solidly” and ...

In a report released today, Ruben Roy from Stifel Nicolaus maintained a Buy rating on Ciena (CIEN – Research Report), with a price target of ...

Over the last 7 days, the United States market has experienced a 3.7% decline, although it has shown a 6.9% increase over the past year with earnings projected to grow by 14% annually. In this context ...

Rep. Andrew Garbarino (R., N.Y.), chairman of the House Homeland Security Committee's subcommittee on cybersecurity and infrastructure protection, said the change in administration and leadership at ...